Viewing Study NCT05266105


Ignite Creation Date: 2025-12-25 @ 3:24 AM
Ignite Modification Date: 2025-12-26 @ 2:03 AM
Study NCT ID: NCT05266105
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-11-24
First Post: 2022-02-11
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: A Phase 1 Study of Oral OP-1250 in Combination With Palbociclib in HR+/HER2- Breast Cancer Patients
Sponsor: Olema Pharmaceuticals, Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module